Global Vaccine Adjuvants Market Size study&Forecast, byType, by Application, by Administration and Regional Analysis, 2023-2030

Description

List of Tables

Global Vaccine Adjuvants Market is valued at approximately USD 1.62 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.3% during the forecast period 2023-2030. Adjuvants are the ingredients that are added to the vaccinations to increase effectiveness of the vaccine and improve its response. The expansion of the Vaccine Adjuvants Market is due to

factors such as the increasing incidence of infectious diseases, growing geriatric population and rising awareness towards health and immunization.

The awareness towards vaccination and immunization regarding the prevention of infectious diseases such as HIV and tuberculosis (TB) has gradually increased over a period of time. according to Centers for Disease Control and Prevention, there were 39 million people in the world who were suffering with HIV and this number is expected to reduce by 2% due to rising number of vaccine prevalence. Furthermore, according to World Health Organization, approximately 10.6 million people suffered with Tuberculosis (TB) around the globe. The continuous increase in the number of patients of infectious diseases lead to the rise in health awareness campaigns and immunization programs to reduce the number by using the preventive measures. Moreover, rising healthcare facilities and advancements in formulations are the opportunities through which the Vaccine Adjuvants Market can grow. However, the high cost of production of development may hinder the expansion of the Vaccine Adjuvants Market throughout the forecast period of 2020-2030.

The key regions considered for the Global Vaccine Adjuvants Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to factors such as an increase in investments in R&D and a rise in severe diseases. Consequently, vaccination against both acute and chronic diseases become necessary. Middle East & Africa are expected to grow significantly over the forecast period due to factors such as constantly enhancing medical facilities, which include the availability of medications and increasing financing for research and development to meet the massive unfulfilled needs. This is projected to raise the market share of Vaccine Adjuvants in the particular region.

Major market player included in this report are:

GlaxoSmithKline plc.
Novavax, Inc.
Adjuvance Technologies, Inc.
SPI Pharma
Agenus, Inc.
CSL Limited
InvivoGen
AstrazenecaCroda International Plc
Pfizer Inc.

Recent Developments in the Market:

In May 2023, GSK plc declared that the US Food and Drug Administration approved Arexvy for the treatment of Respiratory Syncytial Virus (RSV) -related Lower Respiratory Tract Disease (LRTD) in patients 60 years of age and older. This is the first ever RSV immunization which is licensed for older people worldwide.
In March 2022, Croda International Plc confirmed the partnership with Statens Serum Institute. They may produce and commercialise a variety of patented cationic adjuvants, CAF which was developed by SSI.

Global Vaccine Adjuvants Market Report Scope:

Historical Data -2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Type, Application, Administration, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Pathogen
Adjuvant emulsion
Particulate
Combination
Others

By Application:

Infectious diseases
Cancer
Others

By Administration:

Oral
Intradermal
Intranasal
Intramuscular
Others

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Vaccine Adjuvants Market, by Region, 2020-2030 (USD Billion)
- 1.2.2. Vaccine Adjuvants Market, by Type,2020-2030 (USD Billion)
- 1.2.3. Vaccine Adjuvants Market, by Application , 2020-2030 (USD Billion)
- 1.2.4. Vaccine Adjuvants Market, by Administration, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Vaccine Adjuvants Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Vaccine Adjuvants Market Dynamics

3.1. Vaccine Adjuvants Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increasing incidence of chronic diseases
  - 3.1.1.2. Growing Geriatric Population
  - 3.1.1.3. Rising awareness towards immunization
  - 3.1.1.4.
- 3.1.2. Market Challenges
  - 3.1.2.1. High Cost of Vaccine Adjuvants
- 3.1.3. Market Opportunities
  - 3.1.3.1. Advancements in Formulation
  - 3.1.3.2. Rising Healthcare Facilities

Chapter 4. Global Vaccine Adjuvants MarketIndustry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Vaccine Adjuvants Market, by Type

5.1. Market Snapshot
5.2. Global Vaccine Adjuvants Market by Type, Performance - Potential Analysis
5.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Type2020-2030 (USD Billion)
5.4. Vaccine Adjuvants Market, Sub Segment Analysis
- 5.4.1. Pathogen
- 5.4.2. Adjuvant emulsion
- 5.4.3. Particulate
- 5.4.4. Combination
- 5.4.5. Others

Chapter 6. Global Vaccine Adjuvants Market, by Application

6.1. Market Snapshot
6.2. Global Vaccine Adjuvants Market by Application , Performance - Potential Analysis
6.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Vaccine Adjuvants Market, Sub Segment Analysis
- 6.4.1. Infectious diseases
- 6.4.2. Cancer
- 6.4.3. Others

Chapter 7. Global Vaccine Adjuvants Market, byAdministration

7.1. Market Snapshot
7.2. Global Vaccine Adjuvants Market by Administration, Performance - Potential Analysis
7.3. Global Vaccine Adjuvants Market Estimates & Forecasts by Administraion2020-2030 (USD Billion)
7.4. Vaccine Adjuvants Market, Sub Segment Analysis
- 7.4.1. Oral
- 7.4.2. Intradermal
- 7.4.3. Intranasal
- 7.4.4. Intramuscular
- 7.4.5. Others

Chapter 8. Global Vaccine Adjuvants Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Vaccine Adjuvants Market, Regional Market Snapshot
8.4. North America Vaccine Adjuvants Market
- 8.4.1. U.S.Vaccine Adjuvants Market
  - 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Administration breakdown estimates & forecasts, 2020-2030
- 8.4.2. CanadaVaccine Adjuvants Market
8.5. Europe Vaccine Adjuvants Market Snapshot
- 8.5.1. U.K. Vaccine Adjuvants Market
- 8.5.2. Germany Vaccine Adjuvants Market
- 8.5.3. France Vaccine Adjuvants Market
- 8.5.4. Spain Vaccine Adjuvants Market
- 8.5.5. Italy Vaccine Adjuvants Market
- 8.5.6. Rest of EuropeVaccine Adjuvants Market
8.6. Asia-PacificVaccine Adjuvants Market Snapshot
- 8.6.1. China Vaccine Adjuvants Market
- 8.6.2. India Vaccine Adjuvants Market
- 8.6.3. JapanVaccine Adjuvants Market
- 8.6.4. Australia Vaccine Adjuvants Market
- 8.6.5. South Korea Vaccine Adjuvants Market
- 8.6.6. Rest of Asia PacificVaccine Adjuvants Market
8.7. Latin America Vaccine Adjuvants Market Snapshot
- 8.7.1. Brazil Vaccine Adjuvants Market
- 8.7.2. MexicoVaccine Adjuvants Market
8.8. Middle East & AfricaVaccine Adjuvants Market
- 8.8.1. Saudi ArabiaVaccine Adjuvants Market
- 8.8.2. South AfricaVaccine Adjuvants Market
- 8.8.3. Rest of Middle East & AfricaVaccine Adjuvants Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. GlaxoSmithKline plc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. ProductSummary
  - 9.3.1.5. Recent Developments
- 9.3.2. Novavax, Inc.
- 9.3.3. Adjuvance Technologies, Inc.
- 9.3.4. SPI Pharma
- 9.3.5. Agenus, Inc.
- 9.3.6. CSL Limited
- 9.3.7. InvivoGen
- 9.3.8. AstrazenecaCroda
- 9.3.9. International Plc
- 9.3.10. Pfizer Inc

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Vaccine Adjuvants Market, report scope
TABLE 2. Global Vaccine Adjuvants Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Vaccine Adjuvants Market estimates & forecasts by Type 2020-2030 (USD Billion)
TABLE 4. Global Vaccine Adjuvants Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Vaccine Adjuvants Market estimates & forecasts by Administration 2020-2030 (USD Billion)
TABLE 6. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Vaccine Adjuvants Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Vaccine Adjuvants Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Vaccine Adjuvants Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Vaccine Adjuvants Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Vaccine Adjuvants Market
TABLE 71. List of primary sources, used in the study of global Vaccine Adjuvants Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Vaccine Adjuvants Market, research methodology
FIG 2. Global Vaccine Adjuvants Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Vaccine Adjuvants Market, key trends 2022
FIG 5. Global Vaccine Adjuvants Market, growth prospects 2023-2030
FIG 6. Global Vaccine Adjuvants Market, porters 5 force model
FIG 7. Global Vaccine Adjuvants Market, pest analysis
FIG 8. Global Vaccine Adjuvants Market, value chain analysis
FIG 9. Global Vaccine Adjuvants Market by segment, 2020& 2030 (USD Billion)
FIG 10. Global Vaccine Adjuvants Market by segment, 2020& 2030 (USD Billion)
FIG 11. Global Vaccine Adjuvants Market by segment, 2020& 2030 (USD Billion)
FIG 12. Global Vaccine Adjuvants Market by segment, 2020& 2030 (USD Billion)
FIG 13. Global Vaccine Adjuvants Market by segment, 2020& 2030 (USD Billion)
FIG 14. Global Vaccine Adjuvants Market, regional snapshot 2020& 2030
FIG 15. North America Vaccine Adjuvants Market 2020& 2030 (USD Billion)
FIG 16. Europe Vaccine Adjuvants Market 2020& 2030 (USD Billion)
FIG 17. Asia pacific Vaccine Adjuvants Market 2020& 2030 (USD Billion)
FIG 18. Latin America Vaccine Adjuvants Market 2020& 2030 (USD Billion)
FIG 19. Middle East & Africa Vaccine Adjuvants Market 2020& 2030 (USD Billion)